Abstract
Again, the clinical syndrome of chronic heart failure (HF) has traditionally been linked to malfunction of the heart as a pump, usually caused by insults to the myocardium. In recent years, there is mounting evidence to support the concept that the complex pathophysiology of heart failure begins with an abnormality of the heart, but then involves dysfunction of most body organs, including the cardiac, peripheral vascular, renal, neurohormonal, immune, as well as the inflammatory systems. The magnitude of these abnormalities has been related to disease progression and subsequent mortality. Less clear, however, is the origin of these derangements and the sequence of triggering mechanisms in the course of the natural history of HF. One of the known abnormalities associated with the complex clinical syndrome of HF is the profound disturbance in the regulation of the autonomic nervous system. The link between peripheral systems activated in HF and the central nervous system as a source of neurohumoral drive has therefore received increasing attention. The key abnormality in HF is the kidneys’ perception of an inadequate circulating volume by various sensors located on critical sites within the circulation. As a result, the normal relationship between intravascular volume and holding capacity, as perceived by these sensing mechanisms, is perturbed. This leads to the activation of various effector mechanisms whose aim is to increase intravascular volume and maintain blood pressure. The kidney is therefore the central site of action for these effectors that increase intravascular volume, and therefore plays a major pathogenetic role in the sodium and water retention in HF. Renal insufficiency is common in patients with HF and is an adverse prognostic factor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Braunwald E, Bristow MR (2000) Congestive heart failure: fifty years of progress. Circulation 102:IV14–IV23
Mann DL (1999) Mechanisms and models in heart failure: a combinatorial approach. Circulation 100:999–1008
Jankowska EA, Ponikowski P, Piepoli MF, Banasiak W, Anker SD, Poole-Wilson PA (2006) Autonomic imbalance and immune activation in chronic heart failure – pathophysiological links. Cardiovasc Res 70:434–445
Francis GS, Cohn JN (1986) The autonomic nervous system in congestive heart failure. Annu Rev Med 37:235–247
Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ (2001) Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38:955–962
McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW (2004) Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109:1004–1009
Drexler H (1998) Endothelium as a therapeutic target in heart failure. Circulation 98:2652–2655
Linke A, Recchia F, Zhang X, Hintze TH (2003) Acute and chronic endothelial dysfunction: implications for the development of heart failure. Heart Fail Rev 8:87–97
Packer M (1993) How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease. Am J Cardiol 71:3C–11C
DiBona GF, Sawin LL (1994) Reflex regulation of renal nerve activity in cardiac failure. Am J Physiol 266:R27–R39
Sun SY, Wang W, Zucker IH, Schultz HD (1999) Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J Appl Physiol 86:1273–1282
Ma R, Zucker IH, Wang W (1997) Central gain of the cardiac sympathetic afferent reflex in dogs with heart failure. Am J Physiol 273:H2664–H2671
Ishise H, Asanoi H, Ishizaka S, Joho S, Kameyama T, Umeno K, Inoue H (1998) Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure. J Appl Physiol 84:1234–1241
Motte S, Mathieu M, Brimioulle S, Pensis A, Ray L, Ketelslegers JM, Montano N, Naeije R, van de BP, Entee KM (2005) Respiratory-related heart rate variability in progressive experimental heart failure. Am J Physiol Heart Circ Physiol 289:H1729–H1735
Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82:1724–1729
Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf S (1996) Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation 94:690–697
Grassi G, Seravalle G, Bertinieri G, Turri C, Stella ML, Scopelliti F, Mancia G (2001) Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. Clin Sci (Lond) 101:141–146
Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ (1991) Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 18:464–472
Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P (2005) Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 352:1951–1958
Floras JS (2003) Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. Acta Physiol Scand 177:391–398
Arnold JM, Liu P, Demers C, Dorian P, Giannetti N, Haddad H, Heckman GA, Howlett JG, Ignaszewski A, Johnstone DE, Jong P, McKelvie RS, Moe GW, Parker JD, Rao V, Ross HJ, Sequeira EJ, Svendsen AM, Teo K, Tsuyuki RT, White M (2006) Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 22:23–45
Eckberg DL, Drabinsky M, Braunwald E (1971) Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 285:877–883
Ponikowski P, Anker SD, Chua TP, Szelemej R, Piepoli M, Adamopoulos S, Webb-Peploe K, Harrington D, Banasiak W, Wrabec K, Coats AJ (1997) Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 79:1645–1650
De Ferrari GM, Vanoli E, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ (1991) Vagal reflexes and survival during acute myocardial ischemia in conscious dogs with healed myocardial infarction. Am J Physiol 261:H63–H69
Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ (1991) Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 68:1471–1481
Brody MJ (1988) Central nervous system and mechanisms of hypertension. Clin Physiol Biochem 6:230–239
Rivest S (2001) How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 26:761–788
McKinley MJ, McAllen RM, Pennington GL, Smardencas A, Weisinger RS, Oldfield BJ (1996) Physiological actions of angiotensin II mediated by AT1 and AT2 receptors in the brain. Clin Exp Pharmacol Physiol Suppl 3:S99–S104
McKellar S, Loewy AD (1981) Organization of some brain stem afferents to the paraventricular nucleus of the hypothalamus in the rat. Brain Res 217:351–357
Bealer SL (1995) Preoptic recess ablation selectively increases baroreflex sensitivity to angiotensin II in conscious rats. Peptides 16:1197–1201
Patel KP, Zhang PL, Krukoff TL (1993) Alterations in brain hexokinase activity associated with heart failure in rats. Am J Physiol 265:R923–R928
Vahid-Ansari F, Leenen FH (1998) Pattern of neuronal activation in rats with CHF after myocardial infarction. Am J Physiol 275:H2140–H2146
Sato T, Yoshimura R, Kawada T, Shishido T, Miyano H, Sugimachi M, Sunagawa K (1998) The brain is a possible target for an angiotensin-converting enzyme inhibitor in the treatment of chronic heart failure. J Card Fail 4:139–144
Zhang K, Li YF, Patel KP (2002) Reduced endogenous GABA-mediated inhibition in the PVN on renal nerve discharge in rats with heart failure. Am J Physiol Regul Integr Comp Physiol 282:R1006–R1015
Sawchenko PE (1987) Evidence for differential regulation of corticotropin-releasing factor and vasopressin immunoreactivities in parvocellular neurosecretory and autonomic-related projections of the paraventricular nucleus. Brain Res 437:253–263
Sawchenko PE, Swanson LW (1982) Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J Comp Neurol 205:260–272
McKinley MJ, Allen AM, Burns P, Colvill LM, Oldfield BJ (1998) Interaction of circulating hormones with the brain: the roles of the subfornical organ and the organum vasculosum of the lamina terminalis. Clin Exp Pharmacol Physiol Suppl 25:S61–S67
Porter JP, Brody MJ (1986) A comparison of the hemodynamic effects produced by electrical stimulation of subnuclei of the paraventricular nucleus. Brain Res 375:20–29
Wei SG, Felder RB (2002) Forebrain renin-angiotensin system has a tonic excitatory influence on renal sympathetic nerve activity. Am J Physiol Heart Circ Physiol 282:H890–H895
Zhang K, Mayhan WG, Patel KP (1997) Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity. Am J Physiol 273:R864–R872
Francis J, Weiss RM, Wei SG, Johnson AK, Felder RB (2001) Progression of heart failure after myocardial infarction in the rat. Am J Physiol Regul Integr Comp Physiol 281:R1734–R1745
Francis J, Wei SG, Weiss RM, Beltz T, Johnson AK, Felder RB (2002) Forebrain-mediated adaptations to myocardial infarction in the rat. Am J Physiol Heart Circ Physiol 282:H1898–H1906
Porter JP (1988) Electrical stimulation of paraventricular nucleus increases plasma renin activity. Am J Physiol 254:R325–R330
Porter JP (1988) The renin response to aortic occlusion is enhanced by stimulation of the hypothalamus. Hypertension 12:52–58
Johnson AK, Thunhorst RL (1997) The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration. Front Neuroendocrinol 18:292–353
Lappe RW, Brody MJ (1984) Mechanisms of the central pressor action of angiotensin II in conscious rats. Am J Physiol 246:R56–R62
Bunnemann B, Fuxe K, Ganten D (1992) The brain renin-angiotensin system: localization and general significance. J Cardiovasc Pharmacol 19 Suppl 6:S51–S62
Moe GW (2006) B-type natriuretic peptide in heart failure. Curr Opin Cardiol 21:208–214
De Nicola AF, Seltzer A, Tsutsumi K, Saavedra JM (1993) Effects of deoxycorticosterone acetate (DOCA) and aldosterone on Sar1-angiotensin II binding and angiotensin-converting enzyme binding sites in brain. Cell Mol Neurobiol 13:529–539
Harada E, Yoshimura M, Yasue H, Nakagawa O, Nakagawa M, Harada M, Mizuno Y, Nakayama M, Shimasaki Y, Ito T, Nakamura S, Kuwahara K, Saito Y, Nakao K, Ogawa H (2001) Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation 104:137–139
Sakaguchi K, Chai SY, Jackson B, Johnston CI, Mendelsohn FA (1988) Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography. Hypertension 11:230–238
Yoshimura R, Sato T, Kawada T, Shishido T, Inagaki M, Miyano H, Nakahara T, Miyashita H, Takaki H, Tatewaki T, Yanagiya Y, Sugimachi M, Sunagawa K (2000) Increased brain angiotensin receptor in rats with chronic high-output heart failure. J Card Fail 6:66–72
Zhang ZH, Francis J, Weiss RM, Felder RB (2002) The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure. Am J Physiol Heart Circ Physiol 283:H423–H433
Haywood JR, Fink GD, Buggy J, Phillips MI, Brody MJ (1980) The area postrema plays no role in the pressor action of angiotensin in the rat. Am J Physiol 239:H108–H113
De Nicola AF, Grillo C, Gonzalez S (1992) Physiological, biochemical and molecular mechanisms of salt appetite control by mineralocorticoid action in brain. Braz J Med Biol Res 25:1153–1162
Saravia FE, Grillo CA, Ferrini M, Roig P, Lima AE, de Kloet ER, De Nicola AF (1999) Changes of hypothalamic and plasma vasopressin in rats with deoxycorticosterone-acetate induced salt appetite. J Steroid Biochem Mol Biol 70:47–57
Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ (1997) Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276:800–806
Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K, Felder RB (2001) Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol 281:H2241–H2251
Meldrum DR (1998) Tumor necrosis factor in the heart. Am J Physiol 274:R577–R595
Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL (1998) Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97:1382–1391
Das UN (2000) Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction. Mol Cell Biochem 215:145–152
Antonipillai I, Wang Y, Horton R (1990) Tumor necrosis factor and interleukin-1 may regulate renin secretion. Endocrinology 126:273–278
Turnbull AV, Lee S, Rivier C (1998) Mechanisms of hypothalamic-pituitary-adrenal axis stimulation by immune signals in the adult rat. Ann N Y Acad Sci 840:434–443
Saindon CS, Blecha F, Musch TI, Morgan DA, Fels RJ, Kenney MJ (2001) Effect of cervical vagotomy on sympathetic nerve responses to peripheral interleukin-1beta. Auton Neurosci 87:243–248
Dunn AJ (2000) Cytokine activation of the HPA axis. Ann N Y Acad Sci 917:608–617
Ericsson A, Kovacs KJ, Sawchenko PE (1994) A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14:897–913
Ericsson A, Arias C, Sawchenko PE (1997) Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-11. J Neurosci 17:7166–7179
Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL (2001) Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103:2055–2059
Felder RB, Francis J, Zhang ZH, Wei SG, Weiss RM, Johnson AK (2003) Heart failure and the brain: new perspectives. Am J Physiol Regul Integr Comp Physiol 284:R259–R276
MacNeil BJ, Jansen AH, Janz LJ, Greenberg AH, Nance DM (1997) Peripheral endotoxin increases splenic sympathetic nerve activity via central prostaglandin synthesis. Am J Physiol 273:R609–R614
Priebe HJ, Heimann JC, Hedley-Whyte J (1980) Effects of renal and hepatic venous congestion on renal function in the presence of low and normal cardiac output in dogs. Circ Res 47:883–890
Witte MH, Dumont AE, Clauss RH, Rader B, Levine N, Breed ES (1969) Lymph circulation in congestive heart failure: effect of external thoracic duct drainage. Circulation 39:723–733
Epstein FH, Post RS, McDowell M (1953) The effects of an arteriovenous fistula on renal hemodynamics and electrolyte excretion. J Clin Invest 32:233–241
Friedberg CK, Lasser RP, Allen DF, Furst SE, Gabor GE (1964) Production of chronic elevation of left ventricular end diastolic pressure in dogs: hemodynamic and renal studies. Circ Res 15:1–10
Hollander W, Judson WE (1956) The relationship of cardiovascular and renal hemodynamic function to sodium excretion in patients with severe heart disease but without edema. J Clin Invest 35:970–979
Greenberg TT, Richmond WH, Stocking RA, Gupta PD, Meehan JP, Henry JP (1973) Impaired atrial receptor responses in dogs with heart failure due to tricuspid insufficiency and pulmonary artery stenosis. Circ Res 32:424–433
Zucker IH, Earle AM, Gilmore JP (1977) The mechanism of adaptation of left atrial stretch receptors in dogs with chronic congestive heart failure. J Clin Invest 60:323–331
Wegria R, Entrup RW, Jue J, Hughes M (1967) A new factor in pathogenesis of edema of cardiac origin 465. Am J Physiol 213:94–101
Mellander S, Oberg B (1967) Transcapillary fluid absorption and other vascular reactions in the human forearm during reduction of the circulating blood volume. Acta Physiol Scand 71:37–46
Merrill AJ (1949) Mechanisms of salt and water retention in heart failure. Am J Med 6:357–367
Vander AJ, Wilde WS, Malvin RL, Sullivan LP (1958) Re-examination of salt and water retention in congestive heart failure: significance of renal filtration fraction. Am J Med 25:497–502
Ichikawa I, Pfeffer JM, Pfeffer MA, Hostetter TH, Brenner BM (1984) Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res 55:669–675
Cody RJ, Ljungman S, Covit AB, Kubo SH, Sealey JE, Pondolfino K, Clark M, James G, Laragh JH (1988) Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int 34:361–367
Bell NH, Schedl HP, Bartter FC (1964) An explanation for abnormal water retention and hypoosmolality in congestive heart failure. Am J Med 36:351–360
Bennett WM, Bagby GC Jr, Antonovic JN, Porter GA (1973) Influence of volume expansion on proximal tubular sodium reabsorption in congestive heart failure. Am Heart J 85:55–64
Johnston CI, Davis JO, Robb CA, Mackenzie JW (1968) Plasma renin in chronic experimental heart failure and during renal sodium “escape” from mineralocorticoids. Circ Res 22:113–125
Kirchheim HR, Finke R, Hackenthal E, Lowe W, Persson P (1985) Baroreflex sympathetic activation increases threshold pressure for the pressure-dependent renin release in conscious dogs. Pflugers Arch 405:127–135
Mandin H, Davidman M (1978) Renal function in dogs with acute cardiac tamponade. Am J Physiol 234:F117–F122
Auld RB, Alexander EA, Levinsky NG (1971) Proximal tubular function in dogs with thoracic caval constriction. J Clin Invest 50:2150–2158
Levy M (1972) Effects of acute volume expansion and altered hemodynamics on renal tubular function in chronic caval dogs. J Clin Invest 51:922–938
Friedler RM, Belleau LJ, Martino JA, Earley LE (1967) Hemodynamically induced natriuresis in the presence of sodium retention resulting from constriction of the thoracic inferior vena cava. J Lab Clin Med 69:565–583
Zeidel ML, Brenner BM (1987) Actions of atrial natriuretic peptides on the kidney. Semin Nephrol 7:91–97
Johnson MD, Malvin RL (1977) Stimulation of renal sodium reabsorption by angiotensin II. Am J Physiol 232:F298–F306
Schrier RW, Abraham WT (1999) Hormones and hemodynamics in heart failure. N Engl J Med 341:577–585
Chidsey CA, Braunwald E, Morrow AG (1965) Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure. Am J Med 39:442–451
Leimbach WN Jr, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL (1986) Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73:913–919
Barajas L, Powers K, Wang P (1984) Innervation of the renal cortical tubules: a quantitative study. Am J Physiol 247:F50–F60
Myers BD, Deen WM, Brenner BM (1975) Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res 37:101–110
Bello-Reuss E (1980) Effect of catecholamines on fluid reabsorption by the isolated proximal convoluted tubule. Am J Physiol 238:F347–F352
Packer M (1988) Neurohormonal interactions and adaptations in congestive heart failure. Circulation 77:721–730
Gill JR Jr, Carr AA, Fleischmann LE, Casper AG, Bartter FC (1967) Effects of pentolinium on sodium excretion in dogs with constriction of the vena cava. Am J Physiol 212:191–196
Kon V, Yared A, Ichikawa I (1985) Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive heart failure and acute extracellular fluid volume depletion. J Clin Invest 76:1913–1920
Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, Shaknovich A, Pondolfino K, Clark M, Camargo MJ (1986) Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest 78:1362–1374
Edwards RM (1983) Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels. Am J Physiol 244:F526–F534
Brenner BM, Troy JL, Daugharty TM, MacInnes RM (1973) Quantitative importance of changes in postglomerular colloid osmotic pressure in mediating glomerulotubular balance in the rat. J Clin Invest 52:190–197
Murphy BF, Whitworth JA, Kincaid-Smith P (1984) Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics. Br Med J (Clin Res Ed) 288:844–845
Brown JJ, Davies DL, Johnson VW, Lever AF, Robertson JI (1970) Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J 80:329–342
Genest J, Granger P, De CJ, Boucher R (1968) Endocrine factors in congestive heart failure. Am J Cardiol 22:35–42
Chonko AM, Bay WH, Stein JH, Ferris TF (1977) The role of renin and aldosterone in the salt retention of edema. Am J Med 63:881–889
Dzau VJ, Colucci WS, Hollenberg NK, Williams GH (1981) Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 63:645–651
Harris PJ, Young JA (1977) Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney. Pflugers Arch 367:295–297
Jackson EK, Gerkens JF, Brash AR, Branch RA (1982) Acute renal artery constriction increases renal prostaglandin I2 biosynthesis and renin release in the conscious dog. J Pharmacol Exp Ther 222:410–413
Schor N, Ichikawa I, Brenner BM (1981) Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat. Kidney Int 20:442–451
De Forrest JM, Davis JO, Freeman RH, Seymour AA, Rowe BP, Williams GM, Davis TP (1980) Effects of indomethacin and meclofenamate on renin release and renal hemodynamic function during chronic sodium depletion in conscious dogs. Circ Res 47:99–107
Edwards RM (1985) Effects of prostaglandins on vasoconstrictor action in isolated renal arterioles. Am J Physiol 248:F779–F784
Stokes JB, Kokko JP (1977) Inhibition of sodium transport by prostaglandin E2 across the isolated, perfused rabbit collecting tubule. J Clin Invest 59:1099–1104
Perez Guaita MF, Chiaraviglio E (1980) Effect of prostaglandin E1 and its biosynthesis inhibitor indomethacin on drinking in the rat. Pharmacol Biochem Behav 13:787–792
Iino Y, Imai M (1978) Effects of prostaglandins on Na transport in isolated collecting tubules. Pflugers Arch 373:125–132
Oliver JA, Sciacca RR, Pinto J, Cannon PJ (1981) Participation of the prostaglandins in the control of renal blood flow during acute reduction of cardiac output in the dog. J Clin Invest 67:229–237
Dzau VJ, Packer M, Lilly LS, Swartz SL, Hollenberg NK, Williams GH (1984) Prostaglandins in severe congestive heart failure. Relation to activation of the renin–angiotensin system and hyponatremia. N Engl J Med 310:347–352
Laragh JH (1985) Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med 313:1330–1340
Kohzuki M, Hodsman GP, Johnston CI (1989) Attenuated response to atrial natriuretic peptide in rats with myocardial infarction. Am J Physiol 256:H533–H538
Scriven TA, Burnett JC Jr (1985) Effects of synthetic atrial natriuretic peptide on renal function and renin release in acute experimental heart failure. Circulation 72:892–897
Moe GW, Canepa-Anson R, Armstrong PW (1992) Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure. J Cardiovasc Pharmacol 19:691–700
Charloux A, Piquard F, Doutreleau S, Brandenberger G, Geny B (2003) Mechanisms of renal hyporesponsiveness to ANP in heart failure. Eur J Clin Invest 33:769–778
Sosa RE, Volpe M, Marion DN, Atlas SA, Laragh JH, Vaughan ED Jr, Maack T (1986) Relationship between renal hemodynamic and natriuretic effects of atrial natriuretic factor. Am J Physiol 250:F520–F524
McCullough PA (2002) Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med 3:71–76
Schrier RW (2007) Cardiorenal versus renocardiac syndrome: is there a difference? Nat Clin Pract Nephrol 3:637
Ronco C, House AA, Haapio M (2008) Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med 34:957–962
Haldeman GA, Croft JB, Giles WH, Rashidee A (1999) Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 137:352–360
Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, Moye L, Pfeffer MA, Solomon SD (2006) Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol 17:2886–2891
Goldberg A, Hammerman H, Petcherski S, Zdorovyak A, Yalonetsky S, Kapeliovich M, Agmon Y, Markiewicz W, Aronson D (2005) Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J 150:330–337
Berl T, Henrich W (2006) Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 1:8–18
Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C (2006) An assessment of the RIFLE criteria for acute renal failure in hospitalized patients1. Crit Care Med 34:1913–1917
Meyer TW, Hostetter TH (2007) Uremia. N Engl J Med 357:1316–1325
McCullough PA, Sandberg KR (2004) Chronic kidney disease and sudden death: strategies for prevention. Blood Purif 22:136–142
Drexler H (1997) Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 39:287–324
Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH (1994) Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 74:349–353
Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ (1992) Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 90:2092–2096
Hornig B, Maier V, Drexler H (1996) Physical training improves endothelial function in patients with chronic heart failure. Circulation 93:210–214
Inoue N, Ramasamy S, Fukai T, Nerem RM, Harrison DG (1996) Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells. Circ Res 79:32–37
Rieder MJ, Carmona R, Krieger JE, Pritchard KA Jr, Greene AS (1997) Suppression of angiotensin-converting enzyme expression and activity by shear stress. Circ Res 80:312–319
Belch JJ, Bridges AB, Scott N, Chopra M (1991) Oxygen free radicals and congestive heart failure. Br Heart J 65:245–248
Hornig B, Arakawa N, Kohler C, Drexler H (1998) Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 97:363–368
Groves P, Kurz S, Just H, Drexler H (1995) Role of endogenous bradykinin in human coronary vasomotor control. Circulation 92:3424–3430
Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91:988–998
Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236–241
Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL (1996) Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93:704–711
Aukrust P, Gullestad L, Ueland T, Damas JK, Yndestad A (2005) Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications1. Ann Med 37:74–85
Seta Y, Shan K, Bozkurt B, Oral H, Mann DL (1996) Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 2:243–249
Kapadia S, Dibbs Z, Kurrelmeyer K, Kalra D, Seta Y, Wang F, Bozkurt B, Oral H, Sivasubramanian N, Mann DL (1998) The role of cytokines in the failing human heart. Cardiol Clin 16:645–656, viii
Rauchhaus M, Coats AJ, Anker SD (2000) The endotoxin-lipoprotein hypothesis. Lancet 356:930–933
Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS (1992) Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J Clin Invest 90:389–398
Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387–389
Blum A, Miller H (2001) Pathophysiological role of cytokines in congestive heart failure. Annu Rev Med 52:15–27
Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27:1201–1206
Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O (1995) Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92:1479–1486
Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, Niebauer J, Hooper J, Volk HD, Coats AJ, Anker SD (2000) Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102:3060–3067
Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, Smolen J, Emery P, Harriman G, Feldmann M, Lipsky P (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 354:1932–1939
Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253–259
Bradham WS, Moe G, Wendt KA, Scott AA, Konig A, Romanova M, Naik G, Spinale FG (2002) TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling. Am J Physiol Heart Circ Physiol 282:H1288–H1295
Deswal A, Bozkurt B, Seta Y, Parilti-Eiswirth S, Hayes FA, Blosch C, Mann DL (1999) Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation 99:3224–3226
Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, van Veldhuisen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, Fleming T (2004) Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109:1594–1602
Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107:3133–3140
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Marín-García, J. (2010). Heart Failure and Changes at the Periphery: Vascular, Inflammation, Neurohormonal, and Renal Systems. In: Heart Failure. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-147-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-60761-147-9_12
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-146-2
Online ISBN: 978-1-60761-147-9
eBook Packages: MedicineMedicine (R0)